Pediatric Lyme Disease Clinical Presentation

  • Author: Russell W Steele, MD; Chief Editor: Russell W Steele, MD   more...
 
Updated: Jan 24, 2012
 

History

Most patients with Lyme disease do not recall a tick bite. The clinical presentation depends on the stage at which the disease is recognized: (1) early disease, (2) early disseminated disease, or (3) late disease.

Early disease

Early disease usually develops 7-14 days after a tick bite. Two thirds of patients with Lyme disease present with the typical rash, erythema migrans (EM).[2] The rash may be a confluent patch of erythema or may have central clearing. The rash typically expands over days and is not evanescent. EM is a clinical diagnosis, and serologic testing for children with a single EM lesion is generally not recommended because patients may be seronegative early in the course of illness.

During early disease, with or without the rash, patients may complain of a flulike illness characterized by fever, chills, myalgias, arthralgias, headache, and malaise. In the area of the tick bite, tender adenopathy may be noted.

Early disseminated disease

Early disseminated disease usually develops 3-10 weeks after inoculation. Approximately 25% of individuals infected with B burgdorferi have signs and symptoms of disseminated disease at presentation.

Multiple EM lesions are present. These are relatively small erythematous macules (1-5 cm) and are often oval. Unlike primary single EMs, these lesions can be evanescent and do not show the typical expansion over days.

Patients with early disseminated disease may complain of fever, myalgias, arthralgias, malaise, and headache. Persistent headache alone is a rare presentation of Lyme disease but should be considered in patients in endemic areas during summertime.

Cranioneuropathies, especially peripheral seventh nerve palsy (Bell palsy), are common (3% of Lyme disease). In endemic areas, Lyme disease is the most commonly identified cause of acquired facial palsy, especially in children[3] Headache, absence of previous herpetic lesions, and meningeal symptoms are noted in most pediatric Lyme disease patients with facial palsy.

Aseptic meningitis may develop at this stage. Encephalitis is rare. Carditis may present as complete heart block.

Late disease

Late disease develops weeks to months after inoculation. Its hallmark is arthritis, which tends to involve large joints (the knee is involved in 90% of cases). Arthritis must be differentiated from arthralgia, which is common in early disease.

Most patients presenting with late disease do not have a history of EM, because the rash typically leads to earlier treatment, which prevents the development of late disease.

Next

Physical Examination

Early disease

Physical findings in patients with early disease are as follows:

  • EM rash - Confluent or central clearing, expands over days, not evanescent, more common on head or neck in young children and on extremities in older children, characteristic large (>2 cm) macules, which are round or oval and may be more difficult to recognize on the face, neck, or axilla
  • Fever
  • Myalgias
  • Malaise
  • Arthralgia
  • Patient appears in discomfort due to headache or myalgias
  • Tender adenopathy (local, not diffuse)

Early disseminated disease

Physical findings in patients with early disseminated disease are as follows:

  • Multiple EM lesions: Twenty-five percent of patients with Lyme disease present with multiple EM. Eighty-nine percent of patients with disseminated Lyme disease present with at least one EM lesion.
  • Headache
  • Fever
  • Tender adenopathy (regional or generalized)
  • Conjunctivitis (uncommon, never prominent)
  • Carditis (usually manifests as heart block)
  • Meningismus as a sign of aseptic meningitis
  • Cranioneuropathy, especially cranial nerve VII and Bell palsy (peripheral seventh nerve palsy with decreased unilateral function, including the forehead)

Late disease

In patients with late disease, the typical physical finding is arthritis. Arthritis is located mostly in large joints, especially the knee. Warmth, swelling from effusion, and limited range of motion help distinguish arthritis from simple arthralgia.

Previous
Next

Complications

The agents responsible for babesiosis and ehrlichiosis share the same tick vector as B burgdorferi, making co-infection possible. Severe and even fatal acute infection caused by these agents is more common in asplenic individuals (babesiosis) or older adults (Ehrlichia); however, unlike B burgdorferi, chronic infection by these agents is not observed. To add to the confusion, ehrlichial infection may cause a false-positive result for Lyme disease on immunoglobulin M (IgM) Western blot analysis.

One nonmedical complication of Lyme disease has been the public and media’s misconceptions about the disease. Unfortunately, many clinicians perform too many tests when the prior probability of disease is low, resulting in many false-positive tests.

The combination of nonspecific symptoms and suboptimal test results has led to overtreatment for suspected (but not proven) Lyme disease and to the concept of refractory Lyme disease.

Go to Ophthalmic Aspects of Lyme Disease for complete information on this topic.

Previous
 
 
Contributor Information and Disclosures
Author

Russell W Steele, MD  Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association

Disclosure: Nothing to disclose.

Coauthor(s)

Stephen C Aronoff, MD  Waldo E Nelson Chair and Professor, Department of Pediatrics, Temple University School of Medicine

Stephen C Aronoff, MD is a member of the following medical societies: Pediatric Infectious Diseases Society and Society for Pediatric Research

Disclosure: Nothing to disclose.

Sarah L Wingerter, MD  Attending Physician, Department of Emergency Medicine, St Christopher's Hospital for Children; Clinical Assistant Professor of Pediatrics (Adjunct), Temple University School of Medicine

Sarah L Wingerter, MD is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Specialty Editor Board

Gary J Noel, MD  Professor, Department of Pediatrics, Weill Cornell Medical College; Attending Pediatrician, New York-Presbyterian Hospital

Gary J Noel, MD is a member of the following medical societies: Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Larry I Lutwick, MD  Professor of Medicine, State University of New York Downstate Medical School; Director, Infectious Diseases, Veterans Affairs New York Harbor Health Care System, Brooklyn Campus

Larry I Lutwick, MD is a member of the following medical societies: American College of Physicians and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Chief Editor

Russell W Steele, MD  Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association

Disclosure: Nothing to disclose.

Additional Contributors

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous authors Richard G Bachur, MD, and Marvin Harper, MD, to the development and writing of the source article.

References
  1. Feder HM Jr. Lyme disease in children. Infect Dis Clin North Am. Jun 2008;22(2):315-26, vii. [Medline].

  2. Halperin JJ. Nervous system lyme disease: diagnosis and treatment. Rev Neurol Dis. Winter 2009;6(1):4-12. [Medline].

  3. Nigrovic LE, Thompson AD, Fine AM, Kimia A. Clinical predictors of Lyme disease among children with a peripheral facial palsy at an emergency department in a Lyme disease-endemic area. Pediatrics. Nov 2008;122(5):e1080-5. [Medline].

  4. Cohn KA, Thompson AD, Shah SS, Hines EM, Lyons TW, Welsh EJ, et al. Validation of a clinical prediction rule to distinguish lyme meningitis from aseptic meningitis. Pediatrics. Jan 2012;129(1):e46-53. [Medline].

  5. Burbelo PD, Issa AT, Ching KH, Cohen JI, Iadarola MJ, Marques A. Rapid, simple, quantitative, and highly sensitive antibody detection for lyme disease. Clin Vaccine Immunol. Jun 2010;17(6):904-9. [Medline]. [Full Text].

  6. Li X, McHugh GA, Damle N, Sikand VK, Glickstein L, Steere AC. Burden and viability of Borrelia burgdorferi in skin and joints of patients with erythema migrans or lyme arthritis. Arthritis Rheum. Aug 2011;63(8):2238-47. [Medline].

  7. [Guideline] Halperin JJ, Shapiro ED, Logigian E, Belman AL, Dotevall L, Wormser GP, et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. Jul 3 2007;69(1):91-102. [Medline].

  8. [Guideline] The ILADS Working Group. Evidence-based guidelines for the management of Lyme disease. Expert Rev Anti Infect Ther. 2004;2(1 Suppl):S1-13.

  9. [Guideline] Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. Nov 1 2006;43(9):1089-134. [Medline].

  10. Warshafsky S, Lee DH, Francois LK, Nowakowski J, Nadelman RB, Wormser GP. Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis. J Antimicrob Chemother. Jun 2010;65(6):1137-44. [Medline].

Previous
Next
 
The Ixodes scapularis tick is considerably smaller than the Dermacentor tick. The former is the vector for Lyme disease, granulocytic ehrlichiosis, and babesiosis. The latter is the vector for Rocky Mountain spotted fever. This photo displays an adult I scapularis tick (on the right) next to an adult Dermacentor variabilis; both are next to a common match displayed for scale. Photo by Darlyne Murawski; reproduced with permission.
In general, Ixodes scapularis must be attached for at least 24 hours to transmit the spirochete to the host mammal. Prophylactic antibiotics are more likely to be helpful if feeding is longer. This photo shows 2 I scapularis nymphs. The one on the right is unfed; the other has been feeding for 48 hours. Note its larger size and the fact that the midgut diverticula (delicate brown linear areas on the body) are blurred. Photo by Darlyne Murawski; reproduced with permission.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.